PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment - Lubaba, Anikah (Brac University, 2024)
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.